Compile Data Set for Download or QSAR
Report error Found 2604 of affinity data for UniProtKB/TrEMBL: P05067
TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195591(US9216974,Resorufin | US9333197, Resorufin)
Affinity DataKd:  225nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195600(US9216974, WC-5-1)
Affinity DataKd:  828nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195599(US9216974, WC-5-2)
Affinity DataKd:  800nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195585(US9216974, WC-5-3)
Affinity DataKd:  2.38E+3nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195598(US9216974, WC-5-4)
Affinity DataKd:  537nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195595(US9216974, WC-5-9)
Affinity DataKd:  927nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
Washington University

US Patent
LigandPNGBDBM195588(US9216974, WC-5-31)
Affinity DataKd: >1.00E+4nMAssay Description:To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2016
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465355(CHEMBL4285214 | US10669276, Example 1)
Affinity DataEC50:  5nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446485(N2-(3-(Difluoromethoxy)-4-(3-methyl-1H-1,2,4-triaz...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446487(N2-(3-Fluoro-4-(3-methyl-1H-1,2,4-triazol-1-yl)phe...)
Affinity DataEC50:  16nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465354(CHEMBL4293045 | US10669276, Example 4)
Affinity DataEC50:  7nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446490(N2-(3-Fluoro-4-(5-methyl-1H-1,2,4-triazol-1-yl)phe...)
Affinity DataEC50:  22nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446491(N2-(6-(4-Chloro-1H-imidazol-1-yl)-5-methoxypyridin...)
Affinity DataEC50:  9nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446501(7-(4-Fluorophenyl)-N2-(5-methoxy-6-(4-methyl-1H-im...)
Affinity DataEC50:  5nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446518(7-(3,4-Difluorophenyl)-N2-(3-methoxy-4-(3-methyl-1...)
Affinity DataEC50:  5nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446519(7-(3,4-Difluorophenyl)-N2-(3-fluoro-4-(3-methyl-1H...)
Affinity DataEC50:  26nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446520(7-(4-Fluorophenyl)-N4,5,5-trimethyl-N2-(4-(3-methy...)
Affinity DataEC50:  51nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465359(CHEMBL4279052 | US10669276, Example 11)
Affinity DataEC50:  33nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446522(7-(4-Fluorophenyl)-N4,5,5-trimethyl-N2-(4-(4-methy...)
Affinity DataEC50:  13nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446523(7-(4-Fluorophenyl)-N4,5,5-trimethyl-N2-(6-(3-methy...)
Affinity DataEC50:  23nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446524(N2-(6-(4-Chloro-1H-imidazol-1-yl)-5-methoxypyridin...)
Affinity DataEC50:  10nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446525(7-(3,4-Difluorophenyl)-N2-(5-methoxy-6-(4-methyl-1...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465356(CHEMBL4289270 | US10669276, Example 16)
Affinity DataEC50:  30nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446527(7-(3,3-Difluorocyclobutyl)-N2-(3-methoxy-4-(3-meth...)
Affinity DataEC50:  19nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446528(7-(3,3-Difluorocyclobutyl)-N2-(5-methoxy-6-(4-meth...)
Affinity DataEC50:  14nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446529(7-(2,4-Difluorophenyl)-N2-(3-methoxy-4-(3-methyl-1...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446530(7-(2,4-Difluorophenyl)-N2-(5-methoxy-6-(4-methyl-1...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446531(N2-(3-Methoxy-4-(3-methyl-1H-1,2,4-triazol-1-yl)ph...)
Affinity DataEC50:  72nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446532(N2-(5-Methoxy-6-(4-methyl-1H-imidazol-1-yl)pyridin...)
Affinity DataEC50:  30nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446533(N2-(6-(4-Chloro-1H-imidazol-1-yl)-5-methoxypyridin...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446534(7-(2,4-Difluorophenyl)-N2-(3-fluoro-4-(3-methyl-1H...)
Affinity DataEC50:  22nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465357(CHEMBL4283902 | US10669276, Example 25)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446536(7-(2,4-Difluorophenyl)-N2-(5-fluoro-6-(4-methyl-1H...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446537(7-(4-Fluorophenyl)-N2-(3-methoxy-4-(5-methyl-1,3,4...)
Affinity DataEC50:  30nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465360(CHEMBL4294948 | US10669276, Example 28)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446539(2-((7-(4-Fluorophenyl)-2-((5-methoxy-6-(4-methyl-1...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446540(2-((2-((6-(4-Chloro-1H-imidazol-1-yl)-5-methoxypyr...)
Affinity DataEC50:  11nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465358(CHEMBL4284649 | US10669276, Example 31)
Affinity DataEC50:  15nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446542(7-(4-Fluorophenyl)-N2-(3-methoxy-4-(3-methyl-1H-1,...)
Affinity DataEC50:  10nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446543(7-(4-Fluorophenyl)-N2-(5-methoxy-6-(4-methyl-1H-im...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446544(N2-(3-Fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM50465363(CHEMBL4278310 | US10669276, Example 35)
Affinity DataEC50:  13nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446546(N2-(5-Fluoro-6-(4-methyl-1H-imidazol-1-yl)pyridin-...)
Affinity DataEC50:  14nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446547(N2-(3-Fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446548(N2-(3-Fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446549(7-(4-Fluorophenyl)-N2-(3-methoxy-4-(3-methyl-1H-1,...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446550(7-(4-Fluorophenyl)-N2-(5-methoxy-6-(4-methyl-1H-im...)
Affinity DataEC50:  6nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446551(7-(2,3-Difluorophenyl)-N2-(3-methoxy-4-(3-methyl-1...)
Affinity DataEC50:  9nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446552(7-(2,3-Difluorophenyl)-N2-(5-fluoro-6-(4-methyl-1H...)
Affinity DataEC50:  8nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetAmyloid-beta precursor protein [672-713](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM446553(7-(2,3-Difluorophenyl)-N2-(3-fluoro-4-(4-methyl-1H...)
Affinity DataEC50:  5nMAssay Description:Human neuroglioma H4 cells overexpressing human APP695 with the Swedish double mutation (K595N/M596L) were plated at 30,000 cells/well/100 μl in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

Displayed 1 to 50 (of 2604 total ) | Next | Last >>
Jump to: